Renalytix Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 27.67, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the first quarter 2025. Average receivable collection period, for the Renalytix Plc in Sep 30 2024 quarter, has decreased to 13 days, compared to 16 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 407 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2668, from overall ranking in the fourth quarter 2024 at 2821.

What is Receivable Turnover Ratio?
What is Renalytix Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RNLX Receivables Turnover Ratio	(Sep 30 2024) I. Quarter	(Jun 30 2024) IV. Quarter	(Mar 31 2024) III. Quarter	(Dec 31 2023) II. Quarter	(Sep 30 2023) I. Quarter
Y / Y Receivable Change	-60 %	-42.86 %	-	354.55 %	669.23 %
Y / Y Revenue Change	13.73 %	-82.78 %	-26.1 %	-40.52 %	-52.63 %
Receivable Turnover Ratio (TTM)	27.67	22.89	43	56.48	77.82
RNLX's Total Ranking	# 2668	# 2821	# 2834	# 2813	# 0
Accounts Receivable average collection period days	13	16	8	6	5
Seq. Receivable Change	-60 %	0 %	0 %	0 %	-42.86 %
Seq. Revenue Change	-10.92 %	9.53 %	-24.54 %	54.47 %	-86.51 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 28
Healthcare Sector	# 408
Overall Market	# 2668

Receivable Turnover Ratio Statistics
High	Average	Low
0.29	0.19	0.02
(Mar 31 2024)

RNLX Company Profile • Back to RNLX Efficiency Comparisons • Compare RNLX Receivables Turnover Ratio to its Competitors

Financial Statements
Renalytix Plc's Accounts Receivable	$ 0 Millions	Visit RNLX's Balance sheet
Renalytix Plc's Sales TTM	$ 2 Millions	Visit RNLX's Income Statement
Sources of RNLX's Revenues		Visit RNLX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RNLX's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RNLX's Growth Rates	RNLX's Roa	RNLX's Inventory Turnover Ratio	RNLX's Dividend Comparisons
RNLX's Profitability Ratios	RNLX's Roi	RNLX's Asset Turnover Ratio	RNLX's Dividend Growth
RNLX's Valuation Ratios	RNLX's Roe	RNLX's Financial Strength Ratios	RNLX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Immunome Inc	140.19	$ 10.129 Millions	$ 0.072 Millions
Earth Science Tech Inc	139.91	$ 26.481 Millions	$ 0.189 Millions
Electromedical Technologies Inc	119.72	$ 0.583 Millions	$ 0.005 Millions
Prothena Corporation Public Limited Company	103.39	$ 133.350 Millions	$ 1.290 Millions
Lipocine Inc	103.23	$ 7.935 Millions	$ 0.077 Millions
Logicmark Inc	100.37	$ 10.079 Millions	$ 0.100 Millions
Orthofix Medical Inc	98.55	$ 782.799 Millions	$ 7.944 Millions
Airsculpt Technologies Inc	90.85	$ 188.780 Millions	$ 2.078 Millions
Aclaris Therapeutics Inc	80.90	$ 27.080 Millions	$ 0.335 Millions
Pmgc Holdings Inc	78.85	$ 2.446 Millions	$ 0.031 Millions
Harvard Apparatus Regenerative Technology Inc	78.33	$ 0.235 Millions	$ 0.003 Millions
Lifevantage Corp	68.13	$ 195.263 Millions	$ 2.866 Millions
Stoke Therapeutics Inc	62.53	$ 16.742 Millions	$ 0.268 Millions
Nektar Therapeutics	61.91	$ 93.137 Millions	$ 1.505 Millions
Brookdale Senior Living Inc	61.73	$ 3,099.022 Millions	$ 50.206 Millions
Lucid Diagnostics Inc	57.19	$ 4.189 Millions	$ 0.073 Millions
Mersana Therapeutics inc	54.22	$ 34.837 Millions	$ 0.643 Millions
Pavmed Inc	48.30	$ 4.383 Millions	$ 0.091 Millions
Longduoduo Co Ltd	47.82	$ 6.572 Millions	$ 0.137 Millions
Zeo Scientifix Inc	47.51	$ 4.620 Millions	$ 0.097 Millions
Cervomed Inc	44.74	$ 13.194 Millions	$ 0.295 Millions
Nature s Sunshine Products inc	43.22	$ 445.255 Millions	$ 10.302 Millions
Agape Atp Corporation	43.15	$ 1.354 Millions	$ 0.031 Millions
Electrocore Inc	39.37	$ 22.458 Millions	$ 0.571 Millions
Fonar Corporation	36.37	$ 102.006 Millions	$ 2.804 Millions
Lifemd Inc	34.47	$ 192.420 Millions	$ 5.583 Millions
Ontrak Inc	34.00	$ 10.336 Millions	$ 0.304 Millions
Vivos Therapeutics Inc	33.86	$ 13.340 Millions	$ 0.394 Millions
Xoma Royalty Corporation	33.52	$ 21.606 Millions	$ 0.645 Millions
23andme Holding Co	33.34	$ 191.889 Millions	$ 5.756 Millions

Date modified: 2026-08-31T16:10:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.